Creating the Biopharma Production of the Future – The Power of Opto-Bioproduction

The coming generation of drugs has the proven potential to cure many of the currently incurable diseases such as cancer or autoimmune diseases. But the still horrendous production costs threaten to prevent these innovative drugs from reaching a significant number of patients – and becoming blockbuster drugs.

We are dedicated to addressing one of the most pressing needs of the biopharma industry: making these life-saving medicines economically sustainable – for drug manufacturers, payers and patients.

Ningaloo Biosystems is on a mission to remove the obstacle of the currently unaffordable production by unleashing the full potential of light-driven process controls. This not only paves the way for the full adoption of automation, continuous processing and Industry 4.0 standards in the biopharma industry; It can also provide the key to making these novel biopharmaceuticals available to patients around the world and to enable entirely new medicines.

Join Us on Our Journey to Becoming the Number One Enabler of Affordable Biopharmaceutical Drugs!

The biopharmaceutical market is growing twice as rapidly as conventional drugs.

Thousands of trail-blazing biopharmaceuticals are now in clinical trials but face significant hurdles in making them economically viable.

The main challenges to overcome are quicker time-to market, more automation and continuous processes, higher yield and quality.

The time is now to address these urgent and largely unmet needs with Opto-Bioproduction. Let´s make sure the industry can deliver on the breakthrough cures it is promising to patients worldwide.